Health Care & Life Sciences » Biotechnology | Hemispherx Biopharma Inc.

Hemispherx Biopharma Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
18,194.00
16,108.00
8,910.00
5,868.00
2,107.00
Total Accounts Receivable
-
-
-
-
24.00
Inventories
-
-
1,326.00
-
-
Other Current Assets
358.00
399.00
335.00
1,073.00
1,374.00
Total Current Assets
18,552.00
16,507.00
10,571.00
6,941.00
3,505.00
Net Property, Plant & Equipment
12,099.00
11,938.00
11,237.00
9,514.00
8,586.00
Intangible Assets
1,080.00
861.00
862.00
872.00
858.00
Other Assets
136.00
134.00
134.00
1,546.00
1,258.00
Total Assets
31,867.00
29,440.00
22,804.00
18,873.00
14,207.00
ST Debt & Current Portion LT Debt
33.00
22.00
1.00
-
-
Accounts Payable
1,271.00
2,081.00
1,213.00
887.00
741.00
Other Current Liabilities
1,228.00
2,333.00
1,219.00
1,548.00
1,966.00
Total Current Liabilities
2,532.00
4,436.00
2,433.00
2,435.00
2,707.00
Long-Term Debt
23.00
-
-
-
1,835.00
Other Liabilities
14.00
-
-
940.00
-
Total Liabilities
2,569.00
4,436.00
2,433.00
3,375.00
4,542.00
Common Equity (Total)
29,298.00
25,004.00
20,371.00
15,498.00
8,703.00
Total Shareholders' Equity
29,298.00
25,004.00
20,371.00
15,498.00
8,703.00
Total Equity
29,298.00
25,004.00
20,371.00
15,498.00
8,703.00
Liabilities & Shareholders' Equity
31,867.00
29,440.00
22,804.00
18,873.00
14,207.00
Non-Equity Reserves
-
-
-
-
962.00

About Hemispherx Biopharma

View Profile
Address
2117 South West Highway 484
Ocala Florida 32801
United States
Employees -
Website http://www.hemispherx.net
Updated 09/14/2018
Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon.